Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SRZNW SURROZEN INC C/WTS 01/08/2031 (TO PUR COM)
0.0560.0000.00%
Close
01/27 16:00 ET
High
0.000
Open
0.056
Turnover
0.00
Low
0.000
Pre Close
0.056
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
No Data
Company Overview
More
Surrozen, Inc. is a preclinical stage biotechnology company, which engages in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. It is also focused on developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. The company was founded on August 12, 2015 and is headquartered in South San Francisco, CA.
CEO： Mr. Craig C. Parker
Market： NASDAQ
Listing Date： 08/12/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet